生物制药
生化工程
背景(考古学)
工具箱
表征(材料科学)
化学
关键质量属性
纳米技术
计算机科学
计算生物学
数据科学
生物技术
工程类
古生物学
材料科学
物理化学
粒径
生物
程序设计语言
作者
Tobias Graf,Katrin Heinrich,Ingrid Grunert,Harald Wegele,Markus Haberger,Patrick Bulau,Michael Leiß
标识
DOI:10.1016/j.jpba.2020.113251
摘要
Alongside the success of protein-based bio-therapeutics over the last decades and facilitated by advances both in protein engineering and manufacturing, new product formats progressively enter into the biopharmaceutical industry’s pipelines with major implications on the analytical methods used for their characterization. While conventional approaches have proved sufficient for standard (IgG-like) molecules, the increased complexity of novel formats requires proper adjustments of the employed methodologies, in particular with regard to separation-based techniques coupled to UV/FLD detection. After introducing the status quo for the characterization of biopharmaceuticals in quality control settings, this review provides a comprehensive portrayal of emerging LC–MS based technologies, which have already demonstrated their potential to complement the existing analytical toolbox. In this context, the benefits of native LC–MS and two-/multidimensional LC–MS applications to assess product attributes while preserving the higher-order structure are discussed based on challenges arising from the analysis of complex product formats.
科研通智能强力驱动
Strongly Powered by AbleSci AI